Abstract:Background and objective: Andrographis paniculata (AP) is a traditionally used herbaceous plant, whose main active constituent is andrographolide. Andrographolide derivative medications and herbal preparations of AP are often used to treat respiratory tract infections. This study aims to systematically evaluate the safety of andrographolide derivative medications and herbal preparations of AP based on clinical studies. Methods: English and Chinese databases were searched for all types of clinical studies that reported adverse drug reactions (ADRs) and adverse events (AEs) of andrographolide derivative medications and herbal preparations of AP. The ADRs and AEs were classified according to manifestations, and graded according to severity. Single-rate meta-analysis was performed for ADR incidence using R software. Results: A total of 262 studies were included, including 125 randomized controlled trials, 23 non-randomized controlled trials, 6 case series, and 108 case reports. In 9490 participants using andrographolide derivative injections, 383 (4.04%) reported ADRs. Meta-analysis showed that the ADR incidence of three most frequently used injections of andrographolide derivatives (andrographolide sulfonate, potassium sodium dehydroandrographolide succinate, and potassium dehydroandrographolide succinate) were 5.48% [95% CI (4.47%, 6.72%)], 3.69% [95% CI (2.59%, 4.94%)] and 5.33% [95% CI (3.68%, 7.72%)], respectively, which may be slightly higher than the actual ADR incidence, because only studies that reported the occurrence of ADRs or AEs were included, but studies without ADR and AE were not included. The ADRs of andrographolide derivative injections were mainly gastrointestinal, skin and subcutaneous tissue disorders, and anaphylaxis. Fifty-five patients experienced life-threatening anaphylactic shock, three patients died, and the causation attributed to the andrographolide derivative injection. Other ADRs were mild, moderate or medically significant. Nine herbal preparations of AP were tested in 10 studies, and the reported ADRs were mainly mild to moderate gastrointestinal, skin and subcutaneous tissue disorders. Except for five patients using andrographolide derivative injections eventually died, most of the ADRs were alleviated after drug withdrawal and symptomatic treatment. Conclusions: The ADRs of andrographolide derivative medications are few, but can be life-threatening, mainly gastrointestinal, skin and subcutaneous tissue disorders, and anaphylaxis. Injections of andrographolide derivatives should be used with caution. Herbal preparations of AP are essentially safe. Systematic Review Registration : [website], identifier [registration number]

Insight into the pharmacological effects of andrographolide in musculoskeletal disorders

Biological properties of andrographolide, an active ingredient of Andrographis Paniculata: a narrative review

Andrographolide, a natural anti-inflammatory agent: An Update

Advances in Ameliorating Inflammatory Diseases and Cancers by Andrographolide: Pharmacokinetics, Pharmacodynamics, and Perspective

Andrographolide and its derivatives: Current achievements and future perspectives

A Critical Review of Andrographis Paniculata

Study on the mechanism of andrographolide activation

An Insight into Ethanopharmacology, Phytochemistry, and Pharmacological Properties of Genus Andrographis

Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer

Exploring Synthesis and Medicinal Applications of Andrographolide Derivatives: A Review

Andrographolide in Atherosclerosis: Integrating Network Pharmacology and in Vitro Pharmacological Evaluation

Current Trends on Repurposing and Pharmacological Enhancement of Andrographolide

Andrographolide: Synthetic Methods and Biological Activities

The therapeutic potential of andrographolide in cancer treatment

Discovery of ent-labdane derivatives from Andrographis paniculata and their anti-inflammatory activity

Diterpenoid Lactones With Anti-Inflammatory Effects From The Aerial Parts Of Andrographis Paniculata

Deciphering the potential anti-COVID-19 active ingredients in <i>Andrographis paniculata</i> (Burm. F.) Nees by combination of network pharmacology, molecular docking, and molecular dynamics

Adverse Effects of Andrographolide Derivative Medications Compared to the Safe use of Herbal Preparations of Andrographis paniculata: Results of a Systematic Review and Meta-Analysis of Clinical Studies

Andrographis paniculata: A Review of its Phytochemistry and Pharmacological Activities

Novel wine in an old bottle: Preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases

Andrographolide Enhances Proliferation and Prevents Dedifferentiation of Rabbit Articular Chondrocytes: AnIn VitroStudy